The Swedish National Board of Health and Welfare has published the 2018 version of the Classification of surgical interventions

07

Dec 2017

The Swedish Classification of Care Measures (Klassifikation av vårdåtgärder, KVÅ) contains codes for surgical (Klassifikation av kirurgiska åtgärder, KKÅ) and non-surgical (Klassifikation av medicinska åtgärder, KMÅ) medical interventions. It is managed by the National Board of Health and Welfare (Socialstyrelsen) and updated annually.

Eight new surgical procedure codes for the following procedures will be added in 2018:

  • Partial excision of outer ear (DAB30);
  • Total excision of outer ear (DAB40);
  • Occlusion of anal fistula with fatty tissue (JHD65);
  • Other incision or excision of anal fistula (JHD97);
  • Primary reverse total prosthetic replacement of humeral head without cement (NBB59);
  • Primary reverse total prosthetic replacement of humeral head with hybrid technology (NBB69);
  • Secondary reverse total prosthetic replacement of humeral head without cement (NBC59);
  • Secondary reverse total prosthetic replacement of humeral head with hybrid technology (NBC69).

See full details in the Swedish here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more